Auburn University Grant
Grant from the National Institutes of Health
Project Title: Anti-Giradia Cyst Wall Synthase drugs: In vivo testing (Completed)
This grant will be administered by the principle investigator (PI), AU Contracts and Grants Accounting (CGA), and the AU Office of Sponsored Programs (OSP). The PI will direct the work of the project and direct charge project expenditures to the appropriate project fund. CGA will monitor expenditures, request reimbursement from the sponsoring agency, and submit required financial reports to sponsoring and governmental agencies. OSP will administer changes to award conditions, and assist in ARRA data collection. One sub agreement (under $25K) is budgeted and approved under this grant. The subaward is non-competitive and awarded based on the specific research needs of the principle investigator.
| Grant #: SubAward# | 1R03AI078154-01 |
| CFDA | 93.701 |
| Status | Approved |
| Application Date | 5/5/2009 |
| Award Date | 7/22/2009 |
| Jobs | - |
| Job Description | Completed UNDER BUDGET |
| $ Awarded | $ 76,451.00 |
| $ Recvd/Invd | $ 71,651.80 |
| $ Expended | $ 71,651.80 |
| AU Fund | 219037 |
Last Updated: Jan. 17, 2012
Research Opportunities Doing Business with Auburn Procurement AU Contract & Grants Policies
